Patent · US Active

Macrocyclic hepatitis C serine protease inhibitors

US8124584B2 · kind B2 · utility

4Cited by

0References

46Claims

0Family size

Assignee

Enanta Pharmaceuticals, Inc. · US

Inventors

Zhenwei Miao · San Diego, US
Ying Sun · Waltham, US
Suanne Nakajima · Winchester, US
Datong Tang · Malden, US
Frank Xinhe Wu · Shrewsbury, US
Guoyou Xu · Waltham, US
Yat Sun Or · Watertown, US
Zhe Wang · Wilmington, US

Key dates

Filing date	Jan 9, 2009
Grant date	Feb 28, 2012
Priority date	—
Expiry date	Dec 27, 2029

Classification

Technology area (CPC E)Fixed Constructions
CPC primaryE05F2015/763
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of Formula I, II or III, or a pharmaceutically acceptable salt, ester, or prodrug, thereof:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.